Carlo Pescia

Pathologist at ASST Santi Paolo e Carlo, Milan, Italy. @LaStatale.

[Carlo Pescia @CPescia]

thanks @santir_path for the amazing collaboration!

[Carlo Pescia @CPescia]

Check our latest work on integrative scoring of stromal alterations in primary myelofibrosis, and their impact on prognostic scores. Another proof that morphological evaluation provides very useful insights 😌
@ModernPathology https://t.co/O0nFNmN0I1

[Carlo Pescia @CPescia]

#ASH2024 has been amazing! very excited to have presented our poster on how #AI can help #blast quantitation in bone marrow trephines, revealing the limitations of manual estimation.
A big thanks to Prof Royston, Dr Ros Cooper and the whole Oxford family! @RDMOxford

[Carlo Pescia @CPescia]

Spatial Transcriptomics is a hot topic, but what about the impact of sample artefacts on data quality? Drawing from our experience with bone marrow trephines, we share insights from a pathologist’s perspective.

@LeukemiaJnl

https://t.co/XWB6uIO00w

[Daniel Berney @daniel_berney]

If only it was always this easy. #endopath #thyroid

[Carlo Pescia @CPescia]

@zaniniumberto

[Meredith Herman, DO @MeredithKHerman]

Name a better gig than pathology.
I’ll go first.
None.
#PathTwitter #PathX #pathology

[Carlo Pescia @CPescia]

Happy to share this intriguing case of EBV+ cutaneous extranodal NK/T lymphoma that showed a really indolent behaviour: another confirmation of how unpredictable cutaneous lymphomas can be!
#hemepath #twitterpath

[Springer Pathology @SpringerPath]

Wait and see: a case of EBV + cutaneous extranodal NK/T-type lymphoma with indolent behaviour https://t.co/bDafRJwbjM

[Umberto Zanini, MD @zaniniumberto]

Welcome to the age of average.

https://t.co/QdkGPTjdY0

[Marta Salido, PhD @marta_msalido]

Nice systemic mastocytosis case presentation at #EBMWG23 by Dr Pescia

[Carlo Pescia @CPescia]

@marta_msalido Many thanks!

[Carlo Pescia @CPescia]

@umbozanna ok boomer

[Carlo Pescia @CPescia]

A rare case of urinary bladder hamartoma clinically mimicking an urothelial carcinoma. Another interesting case of benign bladder lesions posing problems of differential diagnosis. Read our report at: https://t.co/LIqToLCXCf
#PathTwitter #uropathology @IJSPjournal

[Carlo Pescia @CPescia]

@umbozanna bruscièttah 👄

[Carlo Pescia @CPescia]

@umbozanna Fornito direttamente in reparto?

[Springer Pathology @SpringerPath]

Virchows Archiv's Annual Review Issue 2023: Advances in the classification of myeloid and lymphoid neoplasms as revealed in the International Consensus Classification, guest edited by Daniel A Arber, Elias Campo, Elaine S. Jaffe, is online now. Read here https://t.co/d6na7sdgCJ

[Vikram Deshpande @Vik_deshpandeMD]

Defining an abnormal p53 immunohistochemical stain in Barrett's esophagus related dysplasia: A single positive cryp… https://t.co/SwrO1kDAaB

[Carlo Pescia @CPescia]

Take a look at our brief report on a rare case of splenic fibroblastic/cytokeratin-positive interstitial reticular cell tumor with review of the literature.

A challenging diagnosis indeed 🔬 #hemepath #spleen #pathtwitter https://t.co/Tu0dtdlCFM

[Carlo Pescia @CPescia]

Late retweet just to say it was a real pleasure to participate to this webinar! Thank you very much for the opportunity @haematopath 🔬
(if you want to see it it’s been registered!)

[European Association for Haematopathology @haematopath]

Join our next webinar on 19 OCT 2022 about Myelodysplasia and mimics.

L. Saft, C. Pescia and J. Grzybowski will give you the opportunity to learn more about the autoimmune inflammatory syndrome, MDS mimickers and much more.
⁠
Register today, it's free: https://t.co/isXFBCCNNb

[Tristan Rutland MBBS FRCPA IFCAP @TristanRutland7]

Case 1

Nasal septum, adult

#ENTpath #Dermpath #BSTpath #Pathresidents #Pathtwitter